UNSPSC 51182401: Calcium chloride

This classification denotes a nutritional supplement and electrolyte replacement agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M4I0D6VV5M. European Medicines Agency schedules Calcium chloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11767MIG. Calcium chloride generally arises in the molecular formula CACL2. The term 'calcium chloride' is a United States Homeopathic Pharmacopoeia Name designation. As of Q4 2014, CALCIUM CHLORIDE remains the US FDA Preferred Term for this commodity.

Calcium chloride bears US NLM identifiers UMLS ID C0006686 and NCI Concept Code C28901. SMILES: [CL-].[CA+2].

UNSPSC 51182401 Calcium chloride is a Commodity code that captures chemical inputs for municipal water treatment, wastewater operations, and facility-maintenance applications. Recent state and local solicitations show governments procuring this and closely related chemicals — sodium bisulfite, parenteral nutrition solutions, and specialized valve components — for treatment plants, correctional facilities, and pollution-control operations. Issuing bodies span municipal water authorities, county wastewater departments, and state corrections systems, with procurement vehicles ranging from competitive bids to requests for information to qualify alternate suppliers. The scope reflects routine consumables purchasing tied to regulatory compliance, operational continuity, and the stringent delivery and quality standards that govern public-health infrastructure.

Activity appears across Florida, Washington State, and Connecticut, with the most recent opportunities concentrated in municipal water pollution control and corrections healthcare. The City of Meriden, Connecticut issued an IFB for sodium bisulfite supply (solicitation B027-15, bids due July 29, 2026) for its Water Pollution Control Facility. Broward County, Florida posted a Request for Information on valve parts and repair services (BLD6232026F23, responses due September 29, 2026) tied to wastewater-treatment permit compliance. The Washington State Department of Corrections issued an RFQQ for parenteral products and services across eight facilities statewide (RFQQK13020, bids due October 7, 2026), with pre-bid conference on September 23, 2026, encouraging participation from certified small, minority-owned, women-owned, and veteran-owned businesses under state set-aside targets and anticipating awards to multiple contractors across three regions. Insurance and bonding requirements are typical; pricing is held firm for initial contract terms.